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Purpose: It  is reported that 25% to 50% of patients with abdominal ortic aneurysms 
(AAA) have severe coronary artery disease (CAD) and should undergo an aggressive 
cardiac workup before AAA repair. In contrast, it has been our policy that patients 
referred for AAA repairs undergo no cardiac testing before surgery. 
Methods: This report reviews the last 113 consecutive patients who underwent elective 
AAA repair by the senior author using this policy. Seventy-four patients (group A) had 
only an electrocardiogram before surgery. The remaining 39 patients (group B) were 
referred having already had additional testing that included a thallium stress test (n = 
20), echocardiogram (n = 18), multiple gated acquisition (MUGA) scan (n = 3), cardiac 
catheterization (  = 8), or some combination of these. 
Results: There was no statistical difference between group A and group B with regard to 
age, sex, tobacco use or history of coronary artery disease, diabetes mellitus, stroke 
(CVA), hypertension, peripheral vascular disease, or chronic obstructive pulmonary 
disease. Group B more commonly had a history of myocardial infarction (41% vs 19%, p < 
0.03) and congestive heart failure (23% vs 7%, p < 0.03). During surgery there was no 
significant differences in blood loss, transfusion requirements, or operative times. There 
were no myocardial infarctions in group A arid two (5.1%) in group B, which was not 
significantly different. Other complications, such as CVA, renal failure, pulmonary 
failure, pneumonia, wound infection, and hemorrhage, were not significantly different 
between the two groups. Postoperative hospital stay was not significantly different. There 
were three deaths in the entire series (2.7%), and only one in group B was cardiac-related 
in a patient with known end-stage cardiac disease and a symptomatic 8 cm AAA. 
Conclusions: These data indicate that most patients with AAA can safely undergo repair 
with no cardiac workup and that cardiac workup before AAA repair contributes little 
information that impacts on treatment or final clinical outcome. We conclude that cardiac 
testing in preparation for AAA repair is not usually necessary and that intraoperative 
hemodynamic management may be the most important variable in determining outcome. 
(J Vasc Surg 1997;25:152-6.) 
The incidence of coronary artery disease (CAD) 
is reported to be 25% to 50% in patients who un- 
dergo elective abdominal aortic aneurysm (AAA) re- 
pair. ~-8 This data has motivated many groups to ob- 
tain preoperative cardiac testing in all patients 
scheduled for AAA repair. 2,3,6,1117 Others advocate 
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selective valuation for those patients with moderate 
to high risk of CAD. ~8-2~ It has been our policy not 
to obtain any extensive preoperative cardiac evalua- 
tion except for an electrocardiogram (ECG) and 
chest roentgenogram. We specifically request that 
the referring physician not perform any additional 
cardiac testing before surgery. However, many of our 
patients are referred having already undergone some 
other cardiac evaluation before we see them initially. 
This provided us with two groups for comparison. 
METHODS 
All patients who underwent elective infrarenal 
AAA repair by the senior author from January 1, 
1990, to May 31, 1995, were enrolled in this retro- 
spective study. Of  these 117 patients, four were ex- 
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Table I. Comparison of  preoperative 
characteristics of patients in groups A and B 
Group A Group B 
(n= 74) (n=39) 
number (%) number (%) 
Age (years) 72.6 + 9.0 72.0 ± 8.4 0.73 
Sex: male 52 (70.3) 31 (79.5) 0.41 
female 22 (29.7) 8 (20.5) 0.41 
PMH: CAD 32 (43.2) 20 (51.3) 0.54 
MI 14 (18.9) 16 (41.0) <0.03 
CHF 5 (6.8) 9 (23.1) <0.03 
COPD 24 (32.4) 8 (20.5) 0.26 
DM 5 (6.8) 7 (17.9) 0.13 
Hypertension 41 (55.4) 21 (53.8) 0.97 
Stroke/TIA 8 (10.8) 8 (20.5) 0.26 
PVD 12 (16.2) 8 (20.5) 0.76 
Smoker 60 (81.1) 35 (89.7) 0.35 
The only significant differences were in group B, which had a 
higher incidence of MI and CHF as part of the medical history. 
eluded because their AAAs were first discovered ur- 
ing cardiac evaluation for increasing angina. 
Medical records were reviewed. Data obtained 
include age, sex, and history of CAD, myocardial 
infarction (MI), congestive heart failure (CHF), 
chronic obstructive pulmonary disease (COPD), dia- 
betes mellitus (DM), hypertension, stroke, transient 
ischemic attacks (TIAs), and peripheral vascular dis- 
ease (PVD). Special attention was made to the pre- 
operative cardiac workup. An ECG and chest roent- 
genogram were obtained in all patients. Other 
diagnostic tests obtained were echocardiogram, per- 
santine thallium stress test, multigated acquisition 
scan (MUGA), or cardiac catheterization. An echo- 
cardiogram was considered positive if it showed an 
ejection fraction (EF) of less than 50% or moderate 
to severe valvular disease. Thallium stress tests were 
positive if reversible areas of ischemia were found. A 
cardiac catheterization was considered positive if a 
stenosis >70% was present or if two or more vessels 
had 50% stenoses. Finally, a positive gated heart pool 
scan was defined as one with a calculated EF of less 
than 50%. 
Total operative time and blood loss were re- 
corded. Intravenous nitroglycerine, beta blockade, 
and other hemodynamic manipulations were admin- 
istered at the discretion of the attending anaesthesi- 
ologist on the basis of cardiac performance. These 
actions were based on intraoperative hemodynamics 
and not on the preoperative evaluation. Complica- 
tions reviewed were MI, strokes, renal failure, pul- 
monary failure, pneumonia, wound infection, chole- 
cystitis, hemorrhage, sepsis, bowel ischemia, and 
death. MI was determined by ECG and elevated 
fractions of  the MB portion of creatine phosphoki- 
Table II. Cardiac testing obtained before 
AAA repair in the 39 patients of  group B 
Positive Negative 
Thallium stress test 7 13 
Echocardiogram 7 11 
Cardiac catheterization 6 2 
MUGA 1 2 
Total 21 28 
Note that most of the tests had negative results. Despite 21 
positive tests, only one patient went on to have a CABG before 
AAA repair. 
nase. Pulmonary failure was considered present if a 
patient remained on a respirator longer than 5 days. 
Length of stay was determined. Statistical analyses 
used were X 2, Student's t test, and Fisher's exact est. 
Significance was accepted for p < 0.05. 
RESULTS 
Of  the 113 patients reviewed, 74 patients (group 
A) had no special preoperative workup beyond an 
ECG and chest roentgenogram. Despite the history 
of MI in 19%, CAD in 43%, and CHF in 7%, there 
were no perioperative MIs in this group and no 
associated eaths. The other 39 patients (group B) 
had some other cardiac evaluation before surgery 
done specifically in preparation for AAA repair. This 
included 20 thallium stress tests, 18 echocardio- 
grams, eight cardiac catheterizations, and three 
MUGA scans. Only one of these patients went on to 
undergo acoronary artery bypass (CABG) procedure 
before his AAA repair. There were two postoperative 
MIs in this group and one cardiac-associated death in 
a patient with end-stage cardiac disease and a symp- 
tomatic 8 cm AAA. 
Medical and smoking histories for each group are 
shown in Table I. With the exception of MI and 
CHF, which were more predominant in group B, the 
two patient populations did not differ. Of  the 49 
tests ordered in group B, 28 (57%) were negative 
(Table II). Significant triple vessel disease was found 
in one patient who underwent an elective CABG 2 
weeks before his AAA repair. No other patient re- 
quired heart surgery or angioplasty. 
During surgery there was no difference in blood 
loss, cell saver or packed red cell transfusion require- 
ments, or operative time. Postoperative l ngth of  
stay was not different despite wide variations in both 
groups (Table III). 
The overall complication rates between group A 
and group B were similar (30% and 31%, respective- 
ly). Even when complications were analyzed individ- 
ually, there was no significant difference between the 
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Table I I I .  Comparison of 
intraoperative ariables 
Group A Group B 
(n = 74) (n=39) p 
Operative time (hr) 2.76 + 1.1 2.53 _+ 0.7 0.23 
EBL (ml) 1146 + 887 1108 -+ 777 0.83 
Cell saver (ml) 522 _+ 433 507 + 357 0.85 
PRBC (units) 1.2 + 1.4 1.2 + 1.6 0.95 
Hospital stay (days) 11.1 + 7.5 14.0 _+ 15.8 0.17 
No significant differences were noted. EBL, Estimated blood loss; 
PRBC, packed red blood cells. 
two groups, although there was a higher rate of MI 
in group B (Table IV). There were three deaths in 
this series, resulting in an overall mortality rate of 
2.7%. Although the two deaths in group B gave this 
group a mortality rate of 5.1%, it was not significantly 
different from group A. Only one death was directly 
caused by cardiac disease, and this patient was in 
group B. 
DISCUSSION 
The natural history of large AAAs, as reported by 
Estes and later by Szilagyi, warrants elective repair 
except for extremely moribund patients. 22,23 Thirty- 
day mortality figures of 0% to 5% with 5-year survival 
rates of  65% to 70% have been reported after elective 
AAA repair. 1,2L24,25 More than a third of  these long- 
term deaths are a result of cardiac disease, s In a series 
of 263 patients scheduled for elective AAA repair 
who underwent cardiac catheterization before sur- 
gery, 31% were found to have severe correctable 
CAD. 26 Dipyridamole-thallium i aging appears to 
have become the screening test of choice, although 
radionuclide angiography has also been proposed as 
a predictor of perioperative cardiac morbidity. 2,1s,27 
Recently dobutamine stress echocardiography as 
become another method advocated for preoperative 
evaluation. 9,1°,17 One report that analyzed patients 
with ejection fractions above and below 35% showed 
no statistical difference in operative mortality or cu- 
mulative life-table survival rates. 2s 
We have practiced apolicy of not obtaining rou- 
tine preoperative cardiac evaluation for elective infra- 
renal AAA repair. Instead, cardiac optimization in 
the perioperative p riod is emphasized. This includes 
volume enhancement, afterload reduction and phar- 
macologic manipulation to obtain a cardiac index of 
2.8 L /min /m 2, systemic vascular resistance l ss than 
1100 dynes/s /cm -s, and pulmonary capillary 
wedge pressure between 8 and 15 mm Hg. All pa- 
tients are monitored with pulmonary artery cathe- 
ters. The catheter may be removed as early as 24 
Table IV. Comparison of complications 
Group A Group B 
n (%) n (%) p 
MI 0 2 (5.1) 0.11 
Stroke 0 0 NS 
Renal failure 3 (4.1) 1 (2.6) 0.57 
Pulmonary failure 3 (4.1) 5 (12.8) 0.09 
Pneumonia 8 (10.8) 3 (7.7) 0.43 
Wound infection 1 (1.4) 0 0.65 
Cholecystitis 2 (2.7) 0 0.43 
Hemorrhage 3 (4.1) 1 (2.6) 0.57 
Sepsis 1 (1.4) 0 0.78 
Ischemic bowel 1 ( 1.4) 0 0.78 
Total 22 (29.7) 12 (30.8) 0.92 
No significant differences are noted for any of  the complications. 
hours after surgery if systemic and pulmonary hemo- 
dynamics are adequate and no oxygen debt remains 
as determined by lactate levels. Additionally, we have 
begun to use intraoperative transesophageal chocar- 
diography and have found it to be extremely sensitive 
to cardiac ischemia so that treatment can be insti- 
tuted readily. 
The mortality rate of an elective CABG is 2%. 29 
The overall mortality rate in our series was 2.7%, 
which is better than or comparable with those re- 
ported in the literature. 1,21,24,2s The cardiac-associ- 
ated mortality rate in our series was 0.9%. Given this 
low rate, we cannot justify the additional 2% mortal- 
ity rate that would result from a CABG. Of  course, 
symptomatic cardiac patients with signs of increasing 
or unstable angina should undergo a complete car- 
diac investigation before AAA repair and may indeed 
require angioplasty or CABG. The patients who un- 
derwent preoperative cardiac testing in this series had 
their diagnostic evaluation for the sole purpose of 
preparation for surgery. The cost of this evaluation 
was $51,177 in 39 patients, or $1312 per patient. 
With 42,000 aortic aneurysm repairs performed each 
year in this country, an additional $55 million would 
be spent annually if all patients had similar evalua- 
tions? °
In our search of the English language literature, 
we were unable to find any data that support the 
proposition that CABG before AAA repair gave su- 
perior results to intensive monitoring of these pa- 
tients during surgery. In a recent prospective study, 
125 patients cheduled for elective A_AA repair un- 
derwent cardiac atheterization. 6 Coronary artery le- 
sions were found in 53% of patients that resulted in 
24 CABGs and four percutaneous transluminal cor- 
onary angioplasty (PTCA) procedures. However the 
early mortality rate in this series was 4%, which is 
similar to other reports in the literature and greater 
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than our mortality rate. Ultimately discovering and 
correcting coronary artery disease in these patients 
did not change the expected mortality rate. 
Our data indicate that those patients who under- 
went cardiac testing tended to be sicker, with signif- 
icantly greater numbers having a history of MI and 
CHF. Only one of  these patients went on to have a 
CABG 2 weeks before his AAA repair. No lesions 
amenable to angioplasty were discovered. The overall 
complication rate was the same for both groups. 
Interestingly, although most reports have found car- 
diac complications to comprise the greatest fraction 
of  postoperative complications, in our series pulmo- 
nary events were the major source of complications. 
Eleven patients (9.7%) had pneumonia, and eight 
patients (7.1%) required prolonged courses of venti- 
lator assistance. No patients in group A and only two 
patients in group B had a postoperative MI. 
Of  the three deaths only one was attributable to 
cardiac disease. The one death in group A occurred 
in a patient with chronic renal insufficiency who de- 
veloped acute renal failure in the postoperative pe- 
riod. The only cardiac-related death in group B was 
in a patient with a symptomatic 8-cm AAA and non- 
reconstructable end-stage CAD. After being rejected 
by another vascular surgeon, we elected to repair his 
AAA with the understanding that he was at a consid- 
erably higher risk than most patients. After surgery 
he had an MI with persistent unstable angina. He 
then developed a massive upper gastrointestinal 
hemorrhage~that necessitated anemergent vagotomy 
and antrectomy, and he subsequently died. The other 
death in group B occurred in a patient who developed a 
leak from the distal anastomosis that required emergent 
return to the operating room. She developed multi- 
system organ failure and died 5 days later. 
The low mortality rate in our series indicates that 
the majority of  patients who undergo AAA repair can 
do so safely without extensive preoperative t sting. 
Given the additional 2% mortality rate of CABG, it 
can be reasoned that subjecting patients to both 
cardiac surgery and AAA repair is rislder than per- 
forming the AAA repair alone in the presence of 
stable CAD. We propose that extensive cardiac eval- 
uation is unnecessary for most patients cheduled for 
AAA repair. Intraoperative monitoring of these pa- 
tients with pulmonary artery catheters and possibly 
transesophageal echocardiography b qualified an- 
aesthesiologists may be much more important in
helping to reduce cardiac related morbidity and mor- 
tality rate. However, we would have to consider the 
costs of  transesophageal ehocardiography and pul- 
monary artery catheter as an additional expense when 
comparing thc total cost to the patient. Of  course, 
any patient with cardiac symptoms that on their own 
warrant further investigation should be fully evalu- 
ated before elective surgery. A prospective series with 
a large number of patients in both groups would 
further define the differences we have seen in this 
study and eliminate the selection bias that occurs 
with this type of retrospective analysis. A total of 680 
patients, with 340 patients in each group, would be 
required to determine whether a significant differ- 
ence occurred between the groups, given that the 
occurrence of  myocardial events are approximately 
5% in most series. Specific endpoints would have to 
be developed for intraoperative anaesthetic manage- 
ment of cardiac performance. 
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